Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects?
- PMID: 22366235
- DOI: 10.1093/eurjhf/hfs022
Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects?
Comment on
-
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.Eur J Heart Fail. 2012 Apr;14(4):395-403. doi: 10.1093/eurjhf/hfs009. Epub 2012 Feb 2. Eur J Heart Fail. 2012. PMID: 22302663
-
Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study.Eur J Heart Fail. 2012 Apr;14(4):414-22. doi: 10.1093/eurjhf/hfs016. Epub 2012 Feb 25. Eur J Heart Fail. 2012. PMID: 22366234 Free PMC article.
Similar articles
-
The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease.Int J Cardiol. 2010 Nov 19;145(2):172-176. doi: 10.1016/j.ijcard.2010.04.082. Epub 2010 Jun 8. Int J Cardiol. 2010. PMID: 20570377 Review.
-
Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.Eur J Heart Fail. 2012 Apr;14(4):395-403. doi: 10.1093/eurjhf/hfs009. Epub 2012 Feb 2. Eur J Heart Fail. 2012. PMID: 22302663
-
Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.Pulm Pharmacol Ther. 2017 Jun;44:16-23. doi: 10.1016/j.pupt.2017.03.001. Epub 2017 Mar 3. Pulm Pharmacol Ther. 2017. PMID: 28263812 Clinical Trial.
-
Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.Eur J Heart Fail. 2010 Dec;12(12):1339-44. doi: 10.1093/eurjhf/hfq157. Epub 2010 Sep 22. Eur J Heart Fail. 2010. PMID: 20861127
-
Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease.Respiration. 2008;75(2):224-38. doi: 10.1159/000111820. Epub 2007 Nov 28. Respiration. 2008. PMID: 18042978 Review.
Cited by
-
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.Drugs. 2017 May;77(7):721-732. doi: 10.1007/s40265-017-0731-3. Drugs. 2017. PMID: 28349353 Review.
-
Longitudinal change in lung function and subsequent risks of cardiovascular events: evidence from four prospective cohort studies.BMC Med. 2021 Jul 2;19(1):153. doi: 10.1186/s12916-021-02023-3. BMC Med. 2021. PMID: 34210292 Free PMC article.
-
β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.Drugs. 2013 Oct;73(15):1653-63. doi: 10.1007/s40265-013-0120-5. Drugs. 2013. PMID: 24127222 Review.
-
CYP1B1, VEGFA, BCL2, and CDKN1A Affect the Development of Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2020 Jan 23;15:167-175. doi: 10.2147/COPD.S220675. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32158203 Free PMC article.
-
Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):166-184. doi: 10.15326/jcopdf.1.2.2014.0134. Chronic Obstr Pulm Dis. 2014. PMID: 28848819 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical